Basic Science Neuropathology

Tumors

Tumor Neuropathology

What You'll Learn

  • The adult diffuse gliomas under WHO CNS5 — how IDH, 1p/19q, and molecular grade define astrocytoma vs oligodendroglioma vs glioblastoma
  • Circumscribed, glioneuronal, ependymal and embryonal tumors and their signature histology
  • Meningeal, nerve-sheath and sellar tumors
  • The key other tumors — CNS lymphoma, metastases, hemangioblastoma

The neuropathology view — histology, IHC and molecular markers per tumor. Clinical neuro-oncology (management) lives in the Neuro-oncology notes.

🔍 High-Yield Pearls
  • WHO CNS5 = integrated diagnosis: histology + molecular. IDH-mutant + 1p/19q codeletion = oligodendroglioma; IDH-mutant + ATRX loss = astrocytoma; IDH-wildtype adult diffuse glioma = glioblastoma if TERT-promoter mutation, EGFR amplification, or +7/−10 — even without necrosis or microvascular proliferation.
  • CDKN2A/B homozygous deletion upgrades an IDH-mutant astrocytoma to CNS WHO grade 4.
  • Glioblastoma buzzwords: pseudopalisading necrosis + microvascular (glomeruloid) proliferation.
  • Pilocytic astrocytoma: biphasic, Rosenthal fibers + eosinophilic granular bodies, KIAA1549::BRAF fusion — grade 1, cerebellar child.
  • Ependymoma: perivascular pseudorosettes + dot/ring EMA; Meningioma: whorls + psammoma bodies, EMA/PR/SSTR2a; Schwannoma: Antoni A/B + Verocay bodies, diffuse S100.
Adult Diffuse Gliomas (WHO CNS5)
TumorHistologyMolecular / grade
Astrocytoma, IDH-mutantInfiltrating fibrillary astrocytes; grade by mitoses/MVP/necrosisIDH1/2 mut, ATRX loss, p53; CDKN2A/B homozygous deletion → grade 4
Oligodendroglioma, IDH-mutant & 1p/19q-codeleted“Fried-egg” clear halos, chicken-wire capillaries, microcalcificationIDH mut + whole-arm 1p/19q codeletion (defining); TERT; grade 2/3
Glioblastoma, IDH-wildtypePleomorphic astrocytic tumor with pseudopalisading necrosis and/or microvascular proliferationIDH-wt plus ≥1 of: TERT promoter mut, EGFR amplification, +7/−10 (= grade 4 even without necrosis/MVP)
Circumscribed & Pediatric Gliomas
TumorHistologyMarker / clue
Pilocytic astrocytoma (grade 1)Biphasic compact/loose; Rosenthal fibers + eosinophilic granular bodies; piloid cellsKIAA1549::BRAF fusion; cerebellum, child; cyst + enhancing mural nodule
Pleomorphic xanthoastrocytomaPleomorphic + lipidized (xanthomatous) cells, EGBs, reticulin networkBRAF V600E; superficial temporal, young; CD34
Diffuse midline glioma, H3 K27-altered (grade 4)Infiltrating; pons/thalamus/cord of childrenH3 K27M (or EZHIP overexpression / EGFR-altered); loss of H3K27me3
Glioneuronal & Neuronal Tumors
TumorHistologyClue
GangliogliomaDysplastic ganglion cells + neoplastic glia; EGBs, CD34, perivascular lymphocytesBRAF V600E; temporal lobe epilepsy, young
DNET“Specific glioneuronal element” — columns of axons lined by oligodendrocyte-like cells with floating neurons in mucinCortical, drug-resistant epilepsy; grade 1
Central neurocytomaUniform round cells, neuropil islands (“fibrillary”), calcificationIntraventricular (foramen of Monro); synaptophysin+
Ependymal Tumors
TumorHistologyMolecular / site
EpendymomaPerivascular pseudorosettes (constant) ± true ependymal rosettes; dot-like/ring EMA, GFAPSupratentorial ZFTA-fusion; posterior-fossa PFA (H3K27me3 loss, worse) / PFB
Subependymoma (grade 1)Clusters of bland nuclei in dense fibrillary matrix + microcysts4th/lateral ventricle, older adult; often incidental
Myxopapillary ependymoma (grade 2)Papillae with myxoid/vascular coresFilum terminale / conus
Embryonal Tumors
TumorHistologyMolecular
Medulloblastoma (grade 4)Small round blue cells, high N:C, Homer-Wright rosettes; desmoplastic/nodular variantGroups: WNT (best), SHH, group 3 (MYC, worst), group 4; cerebellar vermis, child
Atypical teratoid/rhabdoid (ATRT)Rhabdoid cells (eccentric nucleus, inclusion-like cytoplasm) + embryonal areasSMARCB1 (INI1) loss; infant
Meningeal & Nerve-Sheath Tumors
TumorHistologyMarker
MeningiomaWhorls + psammoma bodies, syncytial nuclei, intranuclear pseudoinclusions; grade 2 (atypical: ≥4 mitoses or brain invasion), grade 3 (anaplastic morphology, or TERT-promoter mutation / CDKN2A/B homozygous deletion)EMA, PR, SSTR2a; NF2/22q
SchwannomaAntoni A (compact, Verocay bodies) + Antoni B (loose); hyalinized vesselsDiffuse S100; NF2; vestibular (CPA)
NeurofibromaWavy spindle cells, “shredded carrot” collagen, mast cells; intermixed axonsMixed S100/CD34/neurofilament; NF1
MPNSTHypercellular fascicles, geographic necrosis, high mitosesH3K27me3 loss; NF1; S100 patchy
Sellar Region
TumorHistologyClue
Pituitary adenoma / PitNETMonomorphic cells, loss of acinar reticulin networkHormone IHC + transcription factors (PIT1/TPIT/SF1)
Craniopharyngioma, adamantinomatousPalisading epithelium, stellate reticulum, “wet keratin”, calcification, cholesterol cleftsChild; CTNNB1 (β-catenin)
Craniopharyngioma, papillaryPapillae of squamous epithelium, no wet keratinAdult; BRAF V600E
Other Tumors
TumorHistologyClue
Primary CNS lymphomaAngiocentric sheets of large atypical B-cells (DLBCL); “hoops” of reticulin around vesselsCD20+; EBV+ if immunosuppressed; melts with steroids
MetastasisWell-demarcated, at grey-white junction; morphology of primary; peritumoral edemaLung/breast/melanoma/renal/GI; IHC to source
Hemangioblastoma (grade 1)Rich capillary network + vacuolated stromal cellsCerebellum; VHL; inhibin+; EPO → polycythemia
Choroid plexus papillomaFronds of cuboidal/columnar epithelium on fibrovascular coresVentricle, child; transthyretin+
High-Yield Facts
FindingTumor
1p/19q codeletion + IDH mutOligodendroglioma
Pseudopalisading necrosis + MVPGlioblastoma
Rosenthal fibers + EGBs, KIAA1549::BRAFPilocytic astrocytoma
Perivascular pseudorosettes, dot EMAEpendymoma
Homer-Wright rosettes, small blue cellsMedulloblastoma
Whorls + psammoma bodies, EMA/PRMeningioma
Verocay bodies, S100 diffuseSchwannoma
Wet keratin + calcificationAdamantinomatous craniopharyngioma
Vacuolated stromal cells + capillariesHemangioblastoma (VHL)
References
  • WHO Classification of Tumours of the CNS, 5th ed. IARC; 2021.
  • Louis DN, et al. cIMPACT-NOW updates. Acta Neuropathol. 2018–2020.
🔒

Continue reading — sign in

The full note has more clinical pearls, tables, and board-focused tips. Free account, no fee.